Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Kingworld Medicines Group Ltd. ( (HK:1110) ) has issued an announcement.
Kingworld Medicines Group Ltd. has announced the composition of its board of directors and their respective roles, effective from August 1, 2025. The board includes both executive and independent non-executive directors, with Mr. Zhao Li Sheng serving as Chairman. The announcement outlines the members of three key board committees: Audit, Remuneration, and Nomination, with specific directors assigned to each committee. This restructuring is likely to influence the company’s governance and strategic direction, potentially impacting its operational efficiency and stakeholder confidence.
More about Kingworld Medicines Group Ltd.
Average Trading Volume: 1,026,222
Technical Sentiment Signal: Buy
Current Market Cap: HK$345.7M
For an in-depth examination of 1110 stock, go to TipRanks’ Overview page.